Evidence map›Paper›PMID 19152273›Full record

ArticleThe Journal of organic chemistry2009

Inspirations, discoveries, and future perspectives in total synthesis.

K C Nicolaou

Abstract readHistorical Article
In one paragraph

Article in The Journal of organic chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

K C NicolaouDepartment of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. kcn@scripps.edu

Funding

TOTAL SYNTHESIS OF AZASPIRACIDSR01ES013314 · NIEHS · SCRIPPS RESEARCH INSTITUTE, THE · PI NICOLAOU, K. C. · 2005 to 2011
$3.1M
TOTAL SYNTHESIS OF BREVETOXINSR01GM031398 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI NICOLAOU, K. C. · 1985 to 2000
$324k
TOTAL SYNTHESIS OF CALICHEMICINSR01CA046446 · NCI · UNIVERSITY OF PENNSYLVANIA · PI NICOLAOU, K. C. · 1988 to 1999
–
NCI NIH HHS R01 CA046446NIEHS NIH HHS R01 ES013314NIGMS NIH HHS R01 GM031398
6 · The paper itself

Abstract

The last one hundred years have witnessed a dramatic increase in the power and reach of total synthesis. The pantheon of accomplishments in the field includes the total synthesis of molecules of unimaginable beauty and diversity such as the four discussed in this article: endiandric acids (1982), calicheamicin gamma(1)(I) (1992), Taxol (1994), and brevetoxin B (1995). Chosen from the collection of the molecules synthesized in the author's laboratories, these structures are but a small fraction of the myriad constructed in laboratories around the world over the last century. Their stories, and the background on which they were based, should serve to trace the evolution of the art of chemical synthesis to its present sharp condition, an emergence that occurred as a result of new theories and mechanistic insights, new reactions, new reagents and catalysts, and new synthetic technologies and strategies. Indeed, the advent of chemical synthesis as a whole must be considered as one of the most influential developments of the twentieth century in terms of its impact on society.

Indexed as

AminoglycosidesCarboxylic AcidsChemistry, OrganicEnediynesHistory, 20th CenturyHistory, 21st CenturyMarine ToxinsOxocinsPaclitaxelPolyether ToxinsAminoglycosidesbrevetoxin Bcalicheamicin gamma(1)ICarboxylic Acidsendiandric acidEnediynesMarine ToxinsOxocinsPaclitaxelPolyether Toxins

Identifiers

PMID19152273
PMCPMC2672623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.